ADC Therapeutics SA (NYSE:ADCT) Receives Consensus Rating of Hold from Analysts

Shares of ADC Therapeutics SA (NYSE:ADCT – Get Free Report) have been given a consensus rating of “Hold” by the seven research firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy […]

Related Keywords

Canada , ,Acadian Asset Management ,Royal Bank ,Affinity Asset Advisors ,Alphacentric Advisors ,Jpmorgan Chase Co ,Get Free Report ,Marketbeat Ratings ,Stock Down ,Asset Management ,Centric Advisors ,Asset Advisors ,Pictet Asset Management ,Get Free ,Adc Therapeutics ,Nyse Adct ,Hadct ,Medical ,Ratings ,Consensus ,